NeoMedLight Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.64M

  • Investors
  • 4

NeoMedLight General Information

Description

Developer of medical devices designed to limit side effects and increase therapeutic efficiency in cancer treatment. The company's device utilizes the emission of light through the woven optic fiber to treat and prevent oral mucositis, radiodermatitis and dermatitis, enabling patients to be treated safely with precise control of treatment parameters and in a reproducible and consistent manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 88-90 Rue Frédéric Faÿs
  • 69100 Villeurbanne
  • France
+33 09
Primary Industry
Therapeutic Devices
Corporate Office
  • 88-90 Rue Frédéric Faÿs
  • 69100 Villeurbanne
  • France
+33 09

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoMedLight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 25-Oct-2019 $2.64M Completed Pre-Clinical Trials
1. Early Stage VC 13-Jan-2015 Completed Startup
To view NeoMedLight’s complete valuation and funding history, request access »

NeoMedLight Patents

NeoMedLight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3105006-B1 Luminous applicator for a treatment by phototherapy, associated control unit and corresponding treatment system Active 19-Dec-2019
EP-4076642-A1 Light applicator for use in a light therapy treatment, control unit and treatment system thereof Pending 19-Dec-2019
FR-3105006-A1 Luminous applicator for treatment by phototherapy, associated control unit and corresponding treatment system Active 19-Dec-2019
EP-3171940-B1 Single-patient textile device for phototherapy treatment and unit comprising such a single-patient textile device Active 25-Jul-2014
EP-3171940-A1 Single-patient textile device for phototherapy treatment and unit comprising such a single-patient textile device Active 25-Jul-2014 A61N5/0621
To view NeoMedLight’s complete patent history, request access »

NeoMedLight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeoMedLight Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Horizon 2020 SME Instrument Government
Angelor Angel Group Minority
Health-angels Rhone-alpes Angel Group Minority
Smalt Capital Asset Manager Minority
To view NeoMedLight’s complete investors history, request access »

NeoMedLight FAQs

  • When was NeoMedLight founded?

    NeoMedLight was founded in 2014.

  • Where is NeoMedLight headquartered?

    NeoMedLight is headquartered in Villeurbanne, France.

  • What is the size of NeoMedLight?

    NeoMedLight has 8 total employees.

  • What industry is NeoMedLight in?

    NeoMedLight’s primary industry is Therapeutic Devices.

  • Is NeoMedLight a private or public company?

    NeoMedLight is a Private company.

  • What is NeoMedLight’s current revenue?

    The current revenue for NeoMedLight is .

  • How much funding has NeoMedLight raised over time?

    NeoMedLight has raised $3.63M.

  • Who are NeoMedLight’s investors?

    Horizon 2020 SME Instrument, Angelor, Health-angels Rhone-alpes, and Smalt Capital have invested in NeoMedLight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »